FDA Import Refusal AEK-9205254-5/10003/1 — EXMED PHARMACUETICALS
The FDA refused shipment AEK-9205254-5/10003/1 from EXMED PHARMACUETICALS (India) on Feb 2, 2026. The refused product falls under Drugs and Biologics — DAPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 2 other import refusals on record.
Refusal Details
- Date
- Feb 2, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PDA70 DAPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75